{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T02:55:53Z","timestamp":1776740153203,"version":"3.51.2"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s11060-023-04332-4","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T14:53:11Z","timestamp":1684162391000},"page":"281-288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Volumetric response and pattern of failure of histone altered high grade glioma in adults following management with radiation therapy"],"prefix":"10.1007","volume":"163","author":[{"given":"A.","family":"Knight","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Horsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Yuile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Yim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Venketesha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kastelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Back","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,15]]},"reference":[{"issue":"1","key":"4332_CR1","first-page":"142","volume":"2","author":"JD Schulte","year":"2020","unstructured":"Schulte JD, Buerki RA, Lapointe S, Molinaro AM, Zhang Y, Villanueva-Meyer JE et al (2020) Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults. Neurooncol Adv 2(1):142","journal-title":"Neurooncol Adv"},{"issue":"3","key":"4332_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10014-017-0287-7","volume":"34","author":"K Yoshimoto","year":"2017","unstructured":"Yoshimoto K, Hatae R, Sangatsuda Y, Suzuki SO, Hata N, Akagi Y et al (2017) Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution. Brain Tumor Pathol 34(3):103\u2013112","journal-title":"Brain Tumor Pathol"},{"issue":"1","key":"4332_CR3","first-page":"007","volume":"2","author":"BJ Theeler","year":"2020","unstructured":"Theeler BJ, Dalal Y, Monje M, Shilatifard A, Suv\u00e0 ML, Aboud O et al (2020) NCI-CONNECT: comprehensive oncology network evaluating rare CNS tumors-histone mutated midline glioma workshop proceedings. Neurooncol Adv 2(1):007","journal-title":"Neurooncol Adv"},{"key":"4332_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/cancers11050660","volume":"11","author":"BR Lowe","year":"2019","unstructured":"Lowe BR, Maxham LA, Hamey JJ, Wilkins MR, Partridge JF (2019) Histone H3 mutations: an updated view of their role in chromatin deregulation and cancer. Cancers (Basel) 11:5","journal-title":"Cancers (Basel)"},{"issue":"2","key":"4332_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.4143\/crt.2020.694","volume":"53","author":"C Park","year":"2021","unstructured":"Park C, Kim TM, Bae JM, Yun H, Kim JW, Choi SH et al (2021) Clinical and genomic characteristics of adult diffuse midline glioma. Cancer Res Treat 53(2):389\u2013398","journal-title":"Cancer Res Treat"},{"issue":"6","key":"4332_CR6","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK et al (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803\u2013820","journal-title":"Acta Neuropathol"},{"issue":"8","key":"4332_CR7","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231\u20131251","journal-title":"Neuro Oncol"},{"issue":"5","key":"4332_CR8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/bpa.12336","volume":"26","author":"DA Solomon","year":"2016","unstructured":"Solomon DA, Wood MD, Tihan T, Bollen AW, Gupta N, Phillips JJ et al (2016) Diffuse midline gliomas with histone H3\u2013K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations. Brain Pathol 26(5):569\u2013580","journal-title":"Brain Pathol"},{"issue":"1","key":"4332_CR9","first-page":"061","volume":"3","author":"T Picart","year":"2021","unstructured":"Picart T, Barritault M, Poncet D, Berner LP, Izquierdo C, Tabouret E et al (2021) Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults. Neurooncol Adv 3(1):061","journal-title":"Neurooncol Adv"},{"issue":"4","key":"4332_CR10","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/jnen\/nly006","volume":"77","author":"EV Daoud","year":"2018","unstructured":"Daoud EV, Rajaram V, Cai C, Oberle RJ, Martin GR, Raisanen JM et al (2018) Adult brainstem gliomas with H3K27M mutation: radiology, pathology, and prognosis. J Neuropathol Exp Neurol 77(4):302\u2013311","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"4332_CR11","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/RLU.0000000000002300","volume":"43","author":"FJ Vettermann","year":"2018","unstructured":"Vettermann FJ, Felsberg J, Reifenberger G, Hasselblatt M, Forbrig R, Berding G et al (2018) Characterization of Diffuse Gliomas With Histone H3\u2013G34 Mutation by MRI and Dynamic 18F-FET PET. Clin Nucl Med 43(12):895\u2013898","journal-title":"Clin Nucl Med"},{"issue":"6","key":"4332_CR12","first-page":"520","volume":"9","author":"A Yuile","year":"2022","unstructured":"Yuile A, Khasraw M, Low JT, Walsh KM, Lipp E, Sy J et al (2022) Patterns of care in adult histone mutant gliomas: results of an international survey. Neurooncol Pract 9(6):520\u2013525","journal-title":"Neurooncol Pract"},{"issue":"1","key":"4332_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12883-021-02548-3","volume":"22","author":"G Metz","year":"2022","unstructured":"Metz G, Jayamanne D, Wheeler H, Wong M, Cook R, Little N et al (2022) Large tumour volume reduction of IDH-mutated anaplastic glioma involving the insular region following radiotherapy. BMC Neurol 22(1):24","journal-title":"BMC Neurol"},{"issue":"4","key":"4332_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.21037\/cco.2017.06.26","volume":"6","author":"M Sharma","year":"2017","unstructured":"Sharma M, Juthani RG, Vogelbaum MA (2017) Updated response assessment criteria for high-grade glioma: beyond the MacDonald criteria. Chin Clin Oncol 6(4):37","journal-title":"Chin Clin Oncol"},{"issue":"2","key":"4332_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s13311-016-0507-6","volume":"14","author":"BM Ellingson","year":"2017","unstructured":"Ellingson BM, Wen PY, Cloughesy TF (2017) Modified criteria for radiographic response assessment in glioblastoma clinical trials. Neurotherapeutics 14(2):307\u2013320","journal-title":"Neurotherapeutics"},{"issue":"10","key":"4332_CR16","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996","journal-title":"N Engl J Med"},{"issue":"8","key":"4332_CR17","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/neuonc\/now274","volume":"19","author":"D Meyronet","year":"2017","unstructured":"Meyronet D, Esteban-Mader M, Bonnet C, Joly MO, Uro-Coste E, Amiel-Benouaich A et al (2017) Characteristics of H3 K27M-mutant gliomas in adults. Neuro Oncol 19(8):1127\u20131134","journal-title":"Neuro Oncol"},{"issue":"1","key":"4332_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s10014-020-00378-8","volume":"38","author":"KY Lim","year":"2021","unstructured":"Lim KY, Won JK, Park CK, Kim SK, Choi SH, Kim T et al (2021) H3 G34-mutant high-grade glioma. Brain Tumor Pathol 38(1):4\u201313","journal-title":"Brain Tumor Pathol"},{"key":"4332_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5414\/NP301085","volume":"2","author":"BK Kleinschmidt-DeMasters","year":"2018","unstructured":"Kleinschmidt-DeMasters BK, Mulcahy Levy JM (2018) H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis. Clin Neuropathol 2:53\u201363","journal-title":"Clin Neuropathol"},{"issue":"4","key":"4332_CR20","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00432-018-02836-5","volume":"145","author":"A Ebrahimi","year":"2019","unstructured":"Ebrahimi A, Skardelly M, Schuhmann MU, Ebinger M, Reuss D, Neumann M et al (2019) High frequency of H3 K27M mutations in adult midline gliomas. J Cancer Res Clin Oncol 145(4):839\u2013850","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"4332_CR21","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/neuros\/nyx265","volume":"82","author":"T Patel","year":"2018","unstructured":"Patel T, Bander ED, Venn RA, Powell T, Cederquist GY, Schaefer PM et al (2018) The role of extent of resection in IDH1 wild-type or mutant low-grade gliomas. Neurosurgery 82(6):808\u2013814","journal-title":"Neurosurgery"},{"issue":"5","key":"4332_CR22","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/neuonc\/noaa225","volume":"23","author":"M Rossi","year":"2021","unstructured":"Rossi M, Gay L, Ambrogi F, Conti Nibali M, Sciortino T, Puglisi G et al (2021) Association of supratotal resection with progression-free survival, malignant transformation, and overall survival in lower-grade gliomas. Neuro Oncol 23(5):812\u2013826","journal-title":"Neuro Oncol"},{"issue":"1","key":"4332_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2009.6.JNS0952","volume":"112","author":"N Sanai","year":"2010","unstructured":"Sanai N, Polley M-Y, Berger MS (2010) Insular glioma resection: assessment of patient morbidity, survival, and tumor progression: clinical article. J Neurosurg JNS 112(1):1\u20139","journal-title":"J Neurosurg JNS"},{"key":"4332_CR24","doi-asserted-by":"crossref","unstructured":"Qiu T, Chanchotisatien A, Qin Z, Wu J, Du Z, Zhang X, et al. Imaging characteristics of adult H3 K27M-mutant gliomas. J Neurosurg. 2019:1\u20139.","DOI":"10.3171\/2020.2.JNS191920a"},{"issue":"1","key":"4332_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/neuonc\/nox149","volume":"20","author":"M Karremann","year":"2018","unstructured":"Karremann M, Gielen GH, Hoffmann M, Wiese M, Colditz N, Warmuth-Metz M et al (2018) Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location. Neuro Oncol 20(1):123\u2013131","journal-title":"Neuro Oncol"},{"issue":"1","key":"4332_CR26","first-page":"143","volume":"4","author":"SL Gardner","year":"2022","unstructured":"Gardner SL, Tarapore RS, Allen J, McGovern SL, Zaky W, Odia Y et al (2022) Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy. Neurooncol Adv 4(1):143","journal-title":"Neurooncol Adv"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04332-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-023-04332-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04332-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T20:32:59Z","timestamp":1685565179000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-023-04332-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["4332"],"URL":"https:\/\/doi.org\/10.1007\/s11060-023-04332-4","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"21 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Data for this study was stored and retrieved from an Ethics approved prospective database approved by the Northern Sydney Local Health District Human Research Ethics Committee (reference LNR\/15\/HAWKE355). All methods were performed in accordance with relevant guidelines and regulations and approved by this committee. Informed consent to participate was obtained from all participants via a clearly stated opt out procedure.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}